EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonary Embolism in Hospitalized COVID-19 Patients in Romania: Prevalence, Risk Factors, Outcomes

Diana-Maria Mateescu iD, Adrian-Cosmin Ilie, Ioana Cotet, Cristina Guse, Camelia-Oana Muresan iD, Ana-Maria Pah, Marius Badalica-Petrescu, Stela Iurciuc, Maria-Laura Craciun, Adina Avram iD, Alexandra Enache

Viruses · 2025

DOI: 10.3390/v17101342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Diana-Maria Mateescu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romani…. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Embolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Pulmonary embolism (PE) is a severe complication of coronavirus disease 2019 (COVID-19), particularly in hospitalized patients. Data from Eastern Europe, including Romania, are limited, despite potential regional differences in demographics, comorbidities, and thromboprophylaxis practices. (2)

Methods

This retrospective cohort study included 395 adults hospitalized with RT-PCR-confirmed COVID-19 at the “Victor Babeș” Clinical Hospital of Infectious Diseases and Pneumophthisiology, Timișoara, Romania, from September 2022 to December 2024. Demographic, clinical, laboratory, and imaging data were extracted from medical records. PE was confirmed by computed tomography pulmonary angiography (CTPA). Group comparisons used chi-square and t-tests, with multivariable logistic regression to identify independent PE predictors. (3)

Results

PE was diagnosed in 47 patients (11.9%). Compared to those without PE, patients with PE had higher D-dimer (5305.00 ± 1251.00 vs. 537.00 ± 203.00 ng/mL, p < 0.001), fibrinogen (6.33 ± 0.74 vs. 3.51 ± 0.60 g/L, p < 0.001), and PT/INR (1.68 ± 0.21 vs. 1.05 ± 0.09, p < 0.001). Prior venous thromboembolism (VTE; 19.1% vs. 8.3%, p = 0.03) and prolonged immobilization (61.7% vs. 23.0%, p < 0.001) were significant risk factors. Intensive care unit (ICU) transfer occurred in 59.6% of PE cases, with a 25.5% in-hospital mortality rate. All PE patients received anticoagulation; 10.6% underwent thrombolysis. (4)

Conclusions

In this Romanian cohort, one of the first large-scale studies in Eastern Europe, PE was prevalent among hospitalized COVID-19 patients, associated with elevated coagulation markers, identifiable risk factors, and high mortality. Early recognition and optimized thromboprophylaxis are critical to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary EmbolismHumansRomaniaMaleFemaleMiddle AgedRisk FactorsRetrospective StudiesAgedHospitalizationPrevalenceSARS-CoV-2AdultAged, 80 and overHospital MortalityFibrin Fibrinogen Degradation ProductsAnticoagulants

Stichwörter der Autor:innen

COVID-19Eastern Europeanticoagulationd-dimerfibrinogenpulmonary embolismthrombosis

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment DAnticoagulants

Autor:innen und Institutionen

  • Department of General Medicine, Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of Public Health and Sanitary Management, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Legal Medicine, Timisoara Institute of Legal Medicine, 300041 Timisoara, Romania.
  • Ethics and Human Identification Research Center, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Discipline of Forensic Medicine, Bioethics, Deontology, and Medical Law, Department of Neuroscience, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

ORCID-Profile: Diana-Maria Mateescu, Camelia-Oana Muresan, Adina Avram

Förderung

  • Victor Babeș University of Medicine and Pharmacy Timișoara
  • Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania

Zitieren

APA

Mateescu, D. M., Ilie, A. C., Cotet, I., Guse, C., Muresan, C. O., Pah, A. M., Badalica-Petrescu, M., Iurciuc, S., Craciun, M. L., Avram, A., & Enache, A. (2025). Pulmonary Embolism in Hospitalized COVID-19 Patients in Romania: Prevalence, Risk Factors, Outcomes. Viruses. https://doi.org/10.3390/v17101342

Vancouver

Mateescu DM, Ilie AC, Cotet I, Guse C, Muresan CO, Pah AM, et al. Pulmonary Embolism in Hospitalized COVID-19 Patients in Romania: Prevalence, Risk Factors, Outcomes. Viruses. 2025. doi:10.3390/v17101342

BibTeX
@article{Mateescu2025,
  author = {Mateescu, Diana-Maria and Ilie, Adrian-Cosmin and Cotet, Ioana and Guse, Cristina and Muresan, Camelia-Oana and Pah, Ana-Maria and Badalica-Petrescu, Marius and Iurciuc, Stela and Craciun, Maria-Laura and Avram, Adina and Enache, Alexandra},
  title = {Pulmonary Embolism in Hospitalized COVID-19 Patients in Romania: Prevalence, Risk Factors, Outcomes},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17101342}
}
Kostenlos starten →